29 studies found for:    paget's disease of bone
Show Display Options
Rank Status Study
21 Completed Combination Chemotherapy With or Without Trastuzumab Followed By an Autologous Stem Cell Transplant and Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer
Condition: Breast Cancer
Interventions: Biological: trastuzumab;   Drug: carboplatin;   Drug: cyclophosphamide;   Drug: melphalan;   Drug: thiotepa;   Procedure: adjuvant therapy;   Procedure: autologous-autologous tandem hematopoietic stem cell transplantation;   Procedure: bone marrow ablation with stem cell support;   Radiation: radiation therapy
22 Completed Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer
Conditions: Adenocarcinoma of the Colon;   Adenocarcinoma of the Gallbladder;   Adenocarcinoma of the Pancreas;   Adenocarcinoma of the Rectum;   Adult Primary Hepatocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Cholangiocarcinoma of the Gallbladder;   Diffuse Adenocarcinoma of the Stomach;   Intestinal Adenocarcinoma of the Stomach;   Male Breast Cancer;   Mixed Adenocarcinoma of the Stomach;   Ovarian Endometrioid Adenocarcinoma;   Paget Disease of the Breast With Intraductal Carcinoma;   Paget Disease of the Breast With Invasive Ductal Carcinoma;   Recurrent Adult Primary Liver Cancer;   Recurrent Breast Cancer;   Recurrent Colon Cancer;   Recurrent Gallbladder Cancer;   Recurrent Gastric Cancer;   Recurrent Malignant Testicular Germ Cell Tumor;   Recurrent Pancreatic Cancer;   Recurrent Rectal Cancer;   Recurrent Salivary Gland Cancer;   Salivary Gland Adenocarcinoma;   Stage II Malignant Testicular Germ Cell Tumor;   Stage II Pancreatic Cancer;   Stage III Colon Cancer;   Stage III Gastric Cancer;   Stage III Malignant Testicular Germ Cell Tumor;   Stage III Pancreatic Cancer;   Stage III Rectal Cancer;   Stage III Salivary Gland Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IV Breast Cancer;   Stage IV Colon Cancer;   Stage IV Gastric Cancer;   Stage IV Pancreatic Cancer;   Stage IV Rectal Cancer;   Stage IV Salivary Gland Cancer;   Thyroid Gland Medullary Carcinoma;   Unresectable Gallbladder Cancer
Interventions: Biological: recombinant fowlpox-CEA(6D)/TRICOM vaccine;   Biological: sargramostim;   Biological: recombinant fowlpox GM-CSF vaccine adjuvant
23 Completed Efficacy and Safety of Zoledronic Acid in the Prevention and Treatment of Corticosteroid Induced Osteoporosis
Condition: Osteoporosis
Intervention: Drug: Zoledronic Acid
24 Completed
Has Results
Observational Study of Incidence Rates of Esophageal Cancer in Women Taking Medications for the Prevention or Treatment of Osteoporosis (MK-0217A-352)
Conditions: Esophageal Cancer;   Squamous Cell Carcinoma;   Adenocarcinoma
Interventions: Drug: Alendronate;   Drug: Etidronate;   Drug: Ibandronate;   Drug: Risedronate;   Drug: Raloxifene
25 Completed S9630, Medroxyprogesterone in Treating Women With Breast Cancer
Conditions: Breast Cancer;   Endometrial Cancer
Interventions: Drug: medroxyprogesterone;   Drug: tamoxifen citrate;   Procedure: adjuvant therapy
26 Recruiting Etidronate for Arterial Calcifications Due to Deficiency in CD73 (ACDC)
Condition: Arterial Calcification Due to CD73-Deficiency (ACDC)
Interventions: Drug: Etidronate;   Procedure: MRI;   Procedure: CT Scan;   Procedure: ABI;   Procedure: Treadmill;   Procedure: Dexa Scan;   Procedure: Hand X-ray
27 Completed Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Biological: filgrastim;   Biological: rituximab;   Drug: carmustine;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: etoposide;   Drug: melphalan;   Procedure: bone marrow ablation with stem cell support;   Procedure: peripheral blood stem cell transplantation
28 Completed Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Biological: alemtuzumab;   Drug: arsenic trioxide;   Drug: azacitidine;   Drug: busulfan;   Drug: clofarabine;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: fludarabine phosphate;   Drug: gemtuzumab ozogamicin;   Drug: melphalan;   Drug: tipifarnib;   Genetic: DNA methylation analysis;   Genetic: cytogenetic analysis;   Genetic: gene expression analysis;   Genetic: mutation analysis;   Other: diagnostic laboratory biomarker analysis;   Other: immunologic technique;   Procedure: allogeneic hematopoietic stem cell transplantation;   Procedure: nonmyeloablative allogeneic hematopoietic stem cell transplantation
29 Completed
Has Results
Safety and Pregnancy Outcomes in Thrombocythemia Patients Exposed to XAGRID® (Anagrelide Hydrochloride) Compared to Other Treatments
Condition: Thrombocythemia, Essential
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-29) Next Page   
Indicates status has not been verified in more than two years